Clinical Oncology Specialist, Lymphoma

The role

This role drives the adoption and growth of Signatera, a personalized ctDNA test, with a focus on lymphoma. You will build strategic partnerships with healthcare providers and expand access to molecular diagnostics.

What you will do

• Achieve and exceed sales objectives by increasing Signatera adoption and expanding the customer base
• Create and implement a comprehensive territory business plan
• Build and strengthen relationships with academic hematologists, medical oncologists, and pathologists
• Collaborate with Key Opinion Leaders and institutional stakeholders to support care pathway development
• Serve as a clinical and product resource for Signatera and molecular diagnostics
• Partner with solid tumor-focused specialists and internal teams to support customer success
• Identify opportunities to increase test utilization and improve workflow efficiency
• Implement strategic sales and marketing initiatives

Required qualifications

• Bachelor's degree
• 5+ years of successful sales experience in hematology/oncology, molecular diagnostics, surgical oncology, or a closely related healthcare field
• Demonstrated track record of meeting or exceeding sales goals
• Strong understanding of academic and community oncology markets, clinical workflows, precision medicine, and reimbursement dynamics
• Ability to travel approximately 50–75% throughout the assigned territory
• Valid driver's license
• Safe driving record

Nice to have

• Experience engaging hematologists, medical oncologists, pathologists, and other oncology decision-makers
• Knowledge of lymphoma, hematologic malignancies, and molecular diagnostic testing

Benefits

• Comprehensive medical, dental, vision, life and disability plans
• Free testing for employees and their immediate families
• Fertility care benefits
• Pregnancy and baby bonding leave
• 401k benefits
• Commuter benefits
• Employee referral program

About the company

Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care.